The expression of PD-L1 was inhibited in the KDM5A knockdown cervical cancer cells and the inhibition could not be relieved by the addition of niraparib, indicating the importance of KDM5A in the regulation of PD-L1 expression by niraparib. Here, KDM5A is linked to cervical carcinoma.